[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Quanli Gao\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":41},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":25,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":5},"100569376",false,"NCT06693440","The Immune Assessment of PD-1 Antibody Therapy in Tumor","The Immune Assessment of PD-1 Antibody Therapy in Tumor - A Case-Control Study","Inclusion Criteria:\n\n1. Age ≥18 years.\n2. Pathologically confirmed malignant tumors.\n3. Complete medical records.\n4. Assessable immune function test data.\n\nExclusion Criteria:\n\n1. Age \\\u003C18 years.\n2. No confirmed tumor pathology.\n3. Untraceable medical records.\n4. Non-assessable immune function tests.","ALL","18 Years",{"count":18,"type":19},3000,"ESTIMATED","OBSERVATIONAL","This retrospective study will leverage previous immune function monitoring results in conjunction with clinical case data at this medical center.",[23,24],"Efficacy, Team","Adverse Event",[26,27,28],"PD(L)-1 inhibitor","efficacy","adverse event","RECRUITING","2024-11-14",{"date":32,"type":33},"2024-11-18","ACTUAL",{"date":35,"type":33},"2021-07-01",{"date":37,"type":19},"2030-11-13",{"name":39,"class":40},"Quanli Gao","OTHER_GOV",""]